Information was received from a consumer and a healthcare provider (hcp) via a company representative regarding a patient receiving baclofen (2000 mcg/ml at 444 mcg/day) and bupivacaine (10 mg/ml at 2.
221 mg/day) via an implanted pump.
It was reported that the patient had increased pain and localized swelling in the back near where his catheter was spliced after a back fusion in 2009.
There were no environmental factors that contributed to the issue.
A dye study was attempted, but the hcp was unable to aspirate so no dye was pushed.
No interventions had yet been taken.
Surgical intervention was planned, but not yet scheduled.
The issue was not resolved at the time of the report, and it was indicated that the hcp had no further information to provide regarding the event.
|
Concomitant products: product id: 8578, lot#: hg23ybl03, implanted: (b)(6) 2019, product type: catheter.
Product id: 8709, serial#: (b)(4), implanted: (b)(6) 2005, product type: catheter.
Other relevant device(s) are: product id: 8578, serial/lot #: (b)(4), ubd: 02-nov-2019, udi#: (b)(4); product id: 8709, serial/lot #: (b)(4), ubd: 17-oct-2007, udi#: (b)(4).
If information is provided in the future, a supplemental report will be issued.
|